ITM Announces Updates to Commercial Leadership [Yahoo! Finance]
Novartis AG (NVS)
Last novartis ag earnings: 4/28 01:00 am
Check Earnings Report
US:NYSE Investor Relations:
novartis.com/investors
Company Research
Source: Yahoo! Finance
Roger Estafanos, currently U.S. general manager and executive vice president, will be appointed Executive Vice President, Global Head of Radiopharmaceuticals Alexander Pironi, currently Senior Vice President, will be named Executive Vice President, Global Head of Radioisotopes New leadership structure aligns with ITM's strategic focus on driving growth across its radiopharmaceutical and radioisotope businesses Garching / Munich, Germany, March 13, 2025 – ITM Isotope Technologies Munich SE (ITM) , a leading radiopharmaceutical biotech company, today announced updates to its commercial leadership. Dr. Sebastian Marx, a member of ITM's Executive Board and Chief Business Officer will step down on July 20, 2025
Read more
Impact Snapshot
Event Time:
NVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVS alerts
High impacting Novartis AG news events
Weekly update
A roundup of the hottest topics
NVS
News
- Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]Yahoo! Finance
- Novartis named first-ever corporate pharmaceutical partner of the National Football League [Yahoo! Finance]Yahoo! Finance
- Novartis named first-ever corporate pharmaceutical partner of the National Football LeaguePR Newswire
- Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients [Yahoo! Finance]Yahoo! Finance
- Why mankind's core challenges have Michael Lee-Chin looking at the atom [Wealth Professional (Canada)]Wealth Professional
NVS
Earnings
- 1/31/25 - Beat
NVS
Sec Filings
- 1/31/25 - Form 6-K
- 1/31/25 - Form 6-K
- 1/31/25 - Form IRANNOTICE
- NVS's page on the SEC website